Open AccessAmlodipine/valsartan fixed-dose combination treatment in the management of hypertension: A double-blind, randomized trial
Author(s) -
Kang-Ling Wang,
WenChung Yu,
TseMin Lu,
Lung-Ching Chen,
HsinBang Leu,
ChernEn Chiang
Publication year - 2020
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000386
Subject(s) - valsartan , medicine , amlodipine , blood pressure , randomization , fixed dose combination , adverse effect , urology , clinical endpoint , randomized controlled trial , cardiology , anesthesia
To compare the fixed-dose combination (FDC) of amlodipine/valsartan 5/80 mg with valsartan 160 mg monotherapy for efficacy and safety in hypertensive patients.